岡山医学会Acta Medica Okayama0030-155813132019第84回日本温泉気候物理医学会総会・学術集会報告171172ENDepartment of Geriatrics, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical SciencesNo potential conflict of interest relevant to this article was reported.岡山医学会Acta Medica Okayama0030-155813132019医療法人社団重仁 まるがめ医療センター169170ENNo potential conflict of interest relevant to this article was reported.岡山医学会Acta Medica Okayama0030-155813132019医師の働き方改革165167ENJunHamadaDepartment of Health Economics and Policy, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical SciencesNo potential conflict of interest relevant to this article was reported.岡山医学会Acta Medica Okayama0030-155813132019薬物相互作用（46―注射薬の配合変化 : 注射薬の物理的・化学的な相互作用）161164ENYosukeMorishitaDepartment of Pharmacy, Okayama University HospitalSatoruEsumiDepartment of Pharmacy, Okayama University HospitalShigekiNishiharaDepartment of Pharmacy, Okayama University HospitalYoshihisaKitamuraDepartment of Pharmacy, Okayama University HospitalToshiakiSendoDepartment of Pharmacy, Okayama University HospitalNo potential conflict of interest relevant to this article was reported.岡山医学会Acta Medica Okayama0030-1558131320192020年度からの医師臨床研修制度の 改正について159160ENAsukaSatoCenter for Graduate Medical Education, Okayama University HospitalHirokoOgawaCenter for Graduate Medical Education, Okayama University HospitalTomokoMiyoshiCenter for Graduate Medical Education, Okayama University HospitalFumioOtsukaCenter for Graduate Medical Education, Okayama University HospitalNo potential conflict of interest relevant to this article was reported.岡山医学会Acta Medica Okayama0030-155813132019患者会と共に展開する遺伝性大腸癌の医療153157ENKohjiTanakayaKohjiDepartment of surgery, Division of cancer genome-based diagnostic and treatment, National hospital organization, Iwakuni clinical centerNo potential conflict of interest relevant to this article was reported.岡山医学会Acta Medica Okayama0030-155813132019岡山県南東部における夜間・休日の耳鼻咽喉科救急診療の実状145152ENNaokiAkisadaDepartment of Otolaryngology, Japanese Red Cross Okayama Hospital, Department of Head and Neck Surgery, Shikoku Cancer CenterHisashiIshiharaDepartment of Otolaryngology, Japanese Red Cross Okayama HospitalMasakoUnoDepartment of Otolaryngology, Kawasaki Medical School General Medical CenterYusukeAkagiDepartment of Otolaryngology, Okayama Medical CenterSoheiKajiwaraDepartment of Otolaryngology, Okayama Medical CenterAkiFukumotoDepartment of Otolaryngology, Okayama Medical CenterTokioWakabayashiDepartment of Otolaryngology, Kawasaki Medical School HospitalAyakoTakeuchiDepartment of Otolaryngology, Japanese Red Cross Okayama HospitalTakeshiAkisadaDepartment of Otolaryngology, Kawasaki Medical School General Medical CenterTo clarify the scenario regarding the emergency medical treatment of patients undergoing otolaryngology in southeastern Okayama Prefecture in Japan, we evaluated the conditions in three hospitals that mainly provide emergency medical treatment to patients undergoing otorhinolaryngology at night or on holidays. The data (age, sex, type of disease, and address) of patients who visited Japanese Red Cross Okayama Hospital, Kawasaki Medical School General Medical Center, and Okayama Medical Center in 2018 were collected and compared. All three hospitals reported many cases of tonsillar abscess and nasal bleeding. In the study population, the number of patients aged ≤10 and 10-20 years were the lowest and highest, respectively. Patients residing in southern Okayama City and Tamano City tended to visit Japanese Red Cross Okayama Hospital or Kawasaki Medical School General Medical Center. Patients residing in northeastern Okayama Prefecture and northern Okayama City tended to visit Okayama Medical Center. A ceiling for the senior physicians’ capacity will be introduced in April 2020, and thus the number of otolaryngology-related treatments performed in Okayama Prefecture is expected to decrease. The otolaryngologyrelated emergency medical treatment in southeastern Okayama Prefecture may collapse. Emergency medical care systems must therefore be considered in the future.No potential conflict of interest relevant to this article was reported.岡山医学会Acta Medica Okayama0030-155813132019ディスペプシア症状を訴えるヘリコバクター・ピロリ感染胃炎に対する除菌治療と，プロトンポンプ阻害剤，消化管運動機能改善剤の組み合わせ治療による症状改善効果の検討139143ENDepartment of Internal Medicine, Tsuyama Chuo HospitalMasayaIwamuroDepartment of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Phamaceutical SciencesTatsuyaToyokawaDepartment of Gastroenterology, Fukuyama Medical CenterRyutaTakenakaDepartment of Internal Medicine, Tsuyama Chuo HospitalMasafumiInoueDepartment of Gastroenterology, Okayama Red Cross HospitalMamoruItoDepartment of Internal Medicine, Okayama Saiseikai General HospitalHiroyukiOkadaDepartment of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry and Phamaceutical SciencesTo investigate whether treatment comprised of Helicobacter pylori eradication followed by the administration of a proton pump inhibitor (PPI) alone and a dual treatment with a PPI plus a prokinetic agent helps relieve symptoms, we treated 26 patients with H. pylori infection and dyspepsia with the sequential treatment and assessed their symptoms. Scores for gastroesophageal reflux disease (GERD) and dyspepsia in a modified F-scale were significantly improved after the eradication of H. pylori, and symptoms were completely relieved in 13 patients. The remaining 13 patients received 4-week treatment with the PPI rabeprazole, and their GERD scores significantly improved after the treatment. The symptoms of five patients completely disappeared ; the other eight patients required dual treatment with a PPI plus the prokinetic acotiamide. Early satiety tended to be relieved after the dual treatment, but the improvement was not significant. Thus, in patients with dyspepsia and an H. pylori infection, the H. pylori should be eradicated first. The administration of a PPI is useful in patients with GERD symptoms, and a PPI+ acotiamide may be beneficial for residual symptoms of early satiety.No potential conflict of interest relevant to this article was reported.岡山医学会Acta Medica Okayama0030-155813132019平成30年度岡山医学会賞 脳神経研究奨励賞（新見賞）135137ENMidoriEdamatsuDepartment of Molecular Biology and Biochemistry, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical SciencesNo potential conflict of interest relevant to this article was reported.岡山医学会Acta Medica Okayama0030-155813132019平成30年度岡山医学会賞 総合研究奨励賞（結城賞）131133ENYuanGaoDepartment of pharmacology, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical SciencesNo potential conflict of interest relevant to this article was reported.岡山医学会Acta Medica Okayama0030-155813132019平成30年度岡山医学会賞 がん研究奨励賞（林原賞・山田賞）127130ENTakuyaKatoDepartment of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical SciencesNo potential conflict of interest relevant to this article was reported.岡山医学会Acta Medica Okayama0030-155813132019平成30年度岡山医学会賞 胸部・循環研究奨励賞（砂田賞）123125ENRyokoUmebayashiDepartment of Nephrology, Rheumatology, Endocrinology and Metabolism, Okayama University HospitalNo potential conflict of interest relevant to this article was reported.